Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.26 (
invertase
)
4,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Expression of
BZI
-1 Delta N, a dominant-negative form of the tobacco (Nicotiana tabacum) basic leucine zipper (bZIP) transcription factor
BZI
-1 leads to severe defects in pollen development which coincides with reduced transcript abundance of the stamen specific
invertase
gene NIN88 and decreased extracellular
invertase
enzymatic activity. This finding suggests a function of
BZI
-1 in regulating carbohydrate supply of the developing pollen.
BZI
-1 heterodimerises with the bZIP factors
BZI
-2,
BZI
-3 and
BZI
-4 in vitro and in planta. Whereas
BZI
-1 exhibits only weak activation properties,
BZI
-1/
BZI
-2 heterodimers strongly activate transcription. Consistently, approaches leading to reduced levels of functional
BZI
-1 or
BZI
-2 both significantly interfere with pollen development, auxin responsiveness and carbohydrate partitioning. In situ hybridisation studies for
BZI
-1 and
BZI
-2 confirmed temporal and spatial overlapping expression patterns in tapetum and pollen supporting functional cooperation of these factors during pollen development. Plants over-expressing
BZI
-4 produce significantly reduced amounts of intact pollen and are also impaired in NIN88 transcription and enzymatic activity.
BZI
-4 homodimer efficiently binds to a G-box located in the NIN88 promoter but exhibits almost no transcriptional activation capacity. As
BZI
-4 does not actively repress transcription, we propose that its homodimer blocks G-box mediated transcription. In summary, these data support a regulatory model in which
BZI
-4 homodimers and
BZI
-1/
BZI
-2 heterodimers perform opposing functions as negative or positive transcriptional regulators during pollen development.
...
PMID:Homo- and heterodimers of tobacco bZIP proteins counteract as positive or negative regulators of transcription during pollen development. 2040